Gastrointestinal Physiology-Regulated Dogs for Bioavailability Evaluation of an Oral Contolled-Release Dosage Form Composed of Pulsatile Release Granules
スポンサーリンク
概要
- 論文の詳細を見る
Gastrointestinal (GI) physiology-regulated beagle dogs (regulated dogs) were regulated by a combined treatment using intramuscular pentagastrin and intravenous atropine sulfate. In the regulated dogs, the gastric pH was shifted to aroung 2,and the GI transit time was prolonged to approximate that in humans. Pranoprofen, an acidic anti-inflammatory agent, was granulated around sucrose seeds, and then coated with low substituted hydroxypropyl cellulose used as a swelling agent to afford plain granules (A-granule). Then, A-granule was coated stepwise with ethyl cellulose used as an outer shell material to afford two kinds of pulsatile release granules (B- ad C-granules). In the dissolution study using pH 1.2 and 6.8 media, A-, B- and C-granules exhibited lag times of 0,1 and 2 h, respectively. Even in intact beagle dogs, the absorption profiles for A- and B-granules corresponded with those expected from the dissolution profiles. In contrast, the bioavailability of C-granule was only 35% in the intact dogs, but was 55% in the regulated dogs. Thus, the absorption of pranoprofen from pulsatile release granules after a longer lag time should be influenced by the location in the GI tract. Next, a controlled-release (CR) dosage form of pranoprofen was tentatively prepared by combining A-, B- and C-granules at the ratio of 3 : 4 : 3 (w/w in contents of pranoprofen). The bioavailability of the CR dosage form was significantly diminished in the intact dogs, being about 70% as much as that in the regulated dogs. Therefore, the regulated dogs would be superior to the intact dogs in avoiding the underestimation of the bioavailability of a CR dosage form with a pulsatile release property.
- 公益社団法人日本薬学会の論文
- 1996-09-15
著者
-
Shibata Masahiro
Research Institute of Applied Electricity,Hokkaido University
-
Sagara Kazuyoshi
Research Laboratories Yoshitomi Pharmaceutical Industries Ltd.
-
Shibata Masahiro
Research Laboratories Yoshitomi Pharmaceutical Industries Ltd.
-
Yamada Ichimaro
Research Laboratories Yoshitomi Pharmaceutical Industries Ltd.
-
MATSUURA Yuko
Research Laboratories, Yoshitomi Pharmaceutical Industries, Ltd.,
-
KAWATA Miwako
Research Laboratories, Yoshitomi Pharmaceutical Industries, Ltd.,
-
Kawata M
Research Laboratories Yoshitomi Pharmaceutical Industries Ltd.
-
Matsuura Yuko
Research Laboratories Yoshitomi Pharmaceutical Industries Ltd.
-
Yamada Ichimaro
Research And Development Division Mitsubishi Tanabe Pharma Corporation
関連論文
- THE EFFECT OF FLUID SHEAR STRESS ON THE MIGRATION AND PROLIFERATION OF CULTURED ENDOTHELIAL CELLS : Pathophysiology, Vessel : PROCEEDINGS OF THE 50th ANNUAL SCIENTIFIC MEETING OF THE JAPANESE CIRCULATION SOCIETY
- Antiviral effects of peginterferon alpha-2b and ribavirin following 24-week monotherapy of telaprevir in Japanese hepatitis C patients
- Gastrointestinal Physiology-Regulated Dogs for Bioavailability Evaluation of an Oral Contolled-Release Dosage Form Composed of Pulsatile Release Granules